North America Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031
The North America Drug Discovery Informatics Market would witness market growth of 9.8% CAGR during the forecast period (2024-2031).
The US market dominated the North America Drug Discovery Informatics Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,741.7 million by 2031. The Canada market is experiencing a CAGR of 12.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 11.3% during (2024 - 2031).
By integrating data from multiple sources, including genomics, proteomics, transcriptomics, and metabolomics, informatics platforms enable researchers to comprehensively understand disease pathways, identify biomarkers, and prioritize potential drug targets for further investigation. Computational methods such as molecular modeling, virtual screening, and structure-activity relationship (SAR) analysis are pivotal in narrowing down vast chemical libraries to identify lead compounds with the greatest likelihood of success.
Furthermore, drug discovery informatics facilitates the assessment of pharmacokinetic and safety properties of lead compounds through in silico ADME-Tox prediction models, guiding compound selection and optimization early in the drug development process. These predictive tools help researchers identify potential risks and optimize compound structures to enhance efficacy, minimize toxicity, and improve overall drug candidate success rates.
In Mexico, cancer is a significant health concern, ranking as the third leading cause of death in the country. Over 195,000 new cancer cases were registered in 2020, with cervical, thyroid, colon, prostate, breast, and thyroid cancers being the most common. The nation reported 90,222 cancer-related fatalities in the same year, highlighting the urgent need for advancements in cancer treatment and drug discovery. The increasing incidence of cancer and the rising death rate from malignant tumors over the past decade underscore the importance of investing in drug discovery informatics to develop more effective and targeted therapies for cancer patients.
Mexico's National Council of Science and Technology (CONACYT) also plays a similar role in supporting R&D initiatives in healthcare, including those related to drug discovery informatics. CONACYT funds projects that contribute to Mexico's scientific and technological development, supporting innovation in the pharmaceutical industry. Hence, the market will expand rapidly in this region.
Based on Application, the market is segmented into Drug Discovery, and Drug Development. Based on Function, the market is segmented into Sequencing & Target Data Analysis, Molecular Modelling, Library & Database Preparation, Docking, and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Oracle Corporation
- Accenture PLC
- Thermo Fisher Scientific, Inc.
- Boehringer Ingelheim International GmbH
- Infosys Limited
- Charles River Laboratories International, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Certara, Inc.
- Jubilant Pharmova Limited
By Application
- Drug Discovery
- Drug Development
- Sequencing & Target Data Analysis
- Molecular Modelling
- Library & Database Preparation
- Docking
- Others
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Others
- US
- Canada
- Mexico
- Rest of North America
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Drug Discovery Informatics Market, by Application
- 1.4.2 North America Drug Discovery Informatics Market, by Function
- 1.4.3 North America Drug Discovery Informatics Market, by End User
- 1.4.4 North America Drug Discovery Informatics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
- 4.4 Porter’s Five Forces Analysis
- Chapter 5. North America Drug Discovery Informatics Market by Application
- 5.1 North America Drug Discovery Market by Country
- 5.2 North America Drug Development Market by Country
- Chapter 6. North America Drug Discovery Informatics Market by Function
- 6.1 North America Sequencing & Target Data Analysis Market by Country
- 6.2 North America Molecular Modelling Market by Country
- 6.3 North America Library & Database Preparation Market by Country
- 6.4 North America Docking Market by Country
- 6.5 North America Others Market by Country
- Chapter 7. North America Drug Discovery Informatics Market by End User
- 7.1 North America Pharmaceutical Companies Market by Country
- 7.2 North America Biotechnology Companies Market by Country
- 7.3 North America Contract Research Organizations Market by Country
- 7.4 North America Others Market by Country
- Chapter 8. North America Drug Discovery Informatics Market by Country
- 8.1 US Drug Discovery Informatics Market
- 8.1.1 US Drug Discovery Informatics Market by Application
- 8.1.2 US Drug Discovery Informatics Market by Function
- 8.1.3 US Drug Discovery Informatics Market by End User
- 8.2 Canada Drug Discovery Informatics Market
- 8.2.1 Canada Drug Discovery Informatics Market by Application
- 8.2.2 Canada Drug Discovery Informatics Market by Function
- 8.2.3 Canada Drug Discovery Informatics Market by End User
- 8.3 Mexico Drug Discovery Informatics Market
- 8.3.1 Mexico Drug Discovery Informatics Market by Application
- 8.3.2 Mexico Drug Discovery Informatics Market by Function
- 8.3.3 Mexico Drug Discovery Informatics Market by End User
- 8.4 Rest of North America Drug Discovery Informatics Market
- 8.4.1 Rest of North America Drug Discovery Informatics Market by Application
- 8.4.2 Rest of North America Drug Discovery Informatics Market by Function
- 8.4.3 Rest of North America Drug Discovery Informatics Market by End User
- Chapter 9. Company Profiles
- 9.1 Oracle Corporation
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 Accenture PLC
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
- 9.3 Thermo Fisher Scientific, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.5.2 Product Launches and Product Expansions:
- 9.3.5.3 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
- 9.4 Boehringer Ingelheim International GmbH
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional & Segmental Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Infosys Limited
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Acquisition and Mergers:
- 9.5.6 SWOT Analysis
- 9.6 Charles River Laboratories International, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Recent strategies and developments:
- 9.6.4.1 Partnerships, Collaborations, and Agreements:
- 9.6.4.2 Acquisition and Mergers:
- 9.6.5 SWOT Analysis
- 9.7 Agilent Technologies, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.5.2 Acquisition and Mergers:
- 9.7.6 SWOT Analysis
- 9.8 Illumina, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segment and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Partnerships, Collaborations, and Agreements:
- 9.8.5.2 Acquisition and Mergers:
- 9.8.6 SWOT Analysis
- 9.9 Certara, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expenses
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Product Launches and Product Expansions:
- 9.9.5.3 Acquisition and Mergers:
- 9.9.6 SWOT Analysis
- 9.10. Jubilant Pharmova Limited
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook